INDSWFTLTD
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Ind Swift's Jawaharpur Unit Gets Certificate Of GMP Compliance From ROF Germany
Dec 24 (Reuters) - Ind Swift Ltd INSW.NS:
IND SWIFT LTD - JAWAHARPUR UNIT GETS CERTIFICATE OF GMP COMPLIANCE FROM ROF GERMANY
Source text: ID:nBSE50dB0M
Further company coverage: INSW.NS
(([email protected];))
Dec 24 (Reuters) - Ind Swift Ltd INSW.NS:
IND SWIFT LTD - JAWAHARPUR UNIT GETS CERTIFICATE OF GMP COMPLIANCE FROM ROF GERMANY
Source text: ID:nBSE50dB0M
Further company coverage: INSW.NS
(([email protected];))
Ind Swift March-Quarter Profit Falls
May 14 (Reuters) - Ind Swift Ltd INSW.NS:
IND SWIFT MARCH-QUARTER PROFIT 375.4 MILLION RUPEES VERSUS PROFIT 531 MILLION RUPEES
IND SWIFT MARCH-QUARTER REVENUE FROM OPERATIONS 1.35 BILLION RUPEES VERSUS 1.06 BILLION RUPEES
Source text for Eikon: ID:nBSE61rPky
Further company coverage: INSW.NS
(([email protected];))
May 14 (Reuters) - Ind Swift Ltd INSW.NS:
IND SWIFT MARCH-QUARTER PROFIT 375.4 MILLION RUPEES VERSUS PROFIT 531 MILLION RUPEES
IND SWIFT MARCH-QUARTER REVENUE FROM OPERATIONS 1.35 BILLION RUPEES VERSUS 1.06 BILLION RUPEES
Source text for Eikon: ID:nBSE61rPky
Further company coverage: INSW.NS
(([email protected];))
Ind Swift Approves Modifications In Merger Of Co With Ind Swift Laboratories
March 8 (Reuters) - Ind Swift Ltd INSW.NS:
APPROVED MODIFICATIONS IN SCHEME OF ARRANGEMENT FOR AMALGAMATION OF CO WITH IND SWIFT LABORATORIES
Source text for Eikon: ID:nBSE3lXVml
Further company coverage: INSW.NS
(([email protected];))
March 8 (Reuters) - Ind Swift Ltd INSW.NS:
APPROVED MODIFICATIONS IN SCHEME OF ARRANGEMENT FOR AMALGAMATION OF CO WITH IND SWIFT LABORATORIES
Source text for Eikon: ID:nBSE3lXVml
Further company coverage: INSW.NS
(([email protected];))
Ind Swift Dec-Quarter Consol Loss Widens
Feb 14 (Reuters) - Ind Swift Ltd INSW.NS:
IND SWIFT DEC-QUARTER CONSOL LOSS 149.7 MILLION RUPEES VERSUS LOSS 10.3 MILLION RUPEES
IND SWIFT DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 1.03 BILLION RUPEES VERSUS 1.07 BILLION RUPEES
Source text for Eikon: ID:nBSE8xVJR
Further company coverage: INSW.NS
(([email protected];))
Feb 14 (Reuters) - Ind Swift Ltd INSW.NS:
IND SWIFT DEC-QUARTER CONSOL LOSS 149.7 MILLION RUPEES VERSUS LOSS 10.3 MILLION RUPEES
IND SWIFT DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 1.03 BILLION RUPEES VERSUS 1.07 BILLION RUPEES
Source text for Eikon: ID:nBSE8xVJR
Further company coverage: INSW.NS
(([email protected];))
Ind Swift Says Office Premises At Plot No 787, Industrial Area, Phase II, Chandigarh Damaged
Oct 3 (Reuters) - Ind Swift Ltd INSW.NS:
OFFICE PREMISES OF THE COMPANY SITUATED AT PLOT NO 787, INDUSTRIAL AREA, PHASE II, CHANDIGARH HAS BEEN DAMAGED
BEEN NO LOSS OR INJURY TO HUMAN LIFE
YET TO ASCERTAIN THE EXACT QUANTUM OF LOSS CAUSED BY THE FIRE
ADEQUATE INSURANCE COVERAGE ALONG WITH PROPER FIRE APPARATUS FOR SAID OFFICE BUILDING
ADEQUATE STEPS ARE BEING UNDERTAKEN TO RESTORE OPERATION OF THE CONCERNED OFFICE PREMISE
Further company coverage: INSW.NS
Oct 3 (Reuters) - Ind Swift Ltd INSW.NS:
OFFICE PREMISES OF THE COMPANY SITUATED AT PLOT NO 787, INDUSTRIAL AREA, PHASE II, CHANDIGARH HAS BEEN DAMAGED
BEEN NO LOSS OR INJURY TO HUMAN LIFE
YET TO ASCERTAIN THE EXACT QUANTUM OF LOSS CAUSED BY THE FIRE
ADEQUATE INSURANCE COVERAGE ALONG WITH PROPER FIRE APPARATUS FOR SAID OFFICE BUILDING
ADEQUATE STEPS ARE BEING UNDERTAKEN TO RESTORE OPERATION OF THE CONCERNED OFFICE PREMISE
Further company coverage: INSW.NS
Ind Swift Says India Tribunal Admitted Insolvency Process Against Co
Sept 13 (Reuters) - Ind Swift Ltd INSW.NS:
INDIA TRIBUNAL ADMITTED CORPORATE INSOLVENCY RESOLUTION PROCESS AGAINST CO
COMPANY HAS INITIATED STEPS TO CHALLENGE ORDER VIA APPEAL BEFORE NCLAT
INSOLVENCY PROCESS ADMITTED AGAINST CO FOR AN OPERATIONAL DEBT OF 31.2 MILLION RUPEES
Source text for Eikon: ID:nBSE7qfWLL
Further company coverage: INSW.NS
(([email protected];))
Sept 13 (Reuters) - Ind Swift Ltd INSW.NS:
INDIA TRIBUNAL ADMITTED CORPORATE INSOLVENCY RESOLUTION PROCESS AGAINST CO
COMPANY HAS INITIATED STEPS TO CHALLENGE ORDER VIA APPEAL BEFORE NCLAT
INSOLVENCY PROCESS ADMITTED AGAINST CO FOR AN OPERATIONAL DEBT OF 31.2 MILLION RUPEES
Source text for Eikon: ID:nBSE7qfWLL
Further company coverage: INSW.NS
(([email protected];))
Ind Swift Ltd March-Qtr Consol Profit 531 Mln Rupees
May 30 (Reuters) - Ind Swift Ltd INSW.NS:
IND SWIFT LTD MARCH-QUARTER CONSOL PROFIT 531 MILLION RUPEES VERSUS LOSS 54.8 MILLION RUPEES
IND SWIFT LTD MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 1.06 BILLION RUPEES VERSUS 1.06 BILLION RUPEES
Source text for Eikon: [ID:]
Further company coverage: INSW.NS
(([email protected];))
May 30 (Reuters) - Ind Swift Ltd INSW.NS:
IND SWIFT LTD MARCH-QUARTER CONSOL PROFIT 531 MILLION RUPEES VERSUS LOSS 54.8 MILLION RUPEES
IND SWIFT LTD MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 1.06 BILLION RUPEES VERSUS 1.06 BILLION RUPEES
Source text for Eikon: [ID:]
Further company coverage: INSW.NS
(([email protected];))
Events:
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Ind-Swift do?
IND-SWIFT, a Chandigarh-based pharmaceutical company established in 1986, focuses on innovative products. It specializes in finished goods dosage, active pharmaceutical ingredients (APIs), and herbal products, aiming to attract global customers.
Who are the competitors of Ind-Swift?
Ind-Swift major competitors are Makers Laboratories, Biofil Chem & Pharma, Achyut Healthcare, Bharat Immunological, JFL Life Sciences, Dipna Pharma., Deccan Health Care. Market Cap of Ind-Swift is ₹93 Crs. While the median market cap of its peers are ₹82 Crs.
Is Ind-Swift financially stable compared to its competitors?
Ind-Swift seems to be less financially stable compared to its competitors. Altman Z score of Ind-Swift is -0.84 and is ranked 8 out of its 8 competitors.
Does Ind-Swift pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Ind-Swift latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Ind-Swift allocated its funds?
Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Capital Work in Progress, Accounts Receivable
How strong is Ind-Swift balance sheet?
Ind-Swift balance sheet is weak and might have solvency issues
Is the profitablity of Ind-Swift improving?
The profit is oscillating. The profit of Ind-Swift is ₹64.39 Crs for TTM, ₹14.23 Crs for Mar 2024 and ₹26.04 Crs for Mar 2023.
Is the debt of Ind-Swift increasing or decreasing?
Yes, The net debt of Ind-Swift is increasing. Latest net debt of Ind-Swift is ₹955 Crs as of Sep-24. This is greater than Mar-24 when it was ₹890 Crs.
Is Ind-Swift stock expensive?
Ind-Swift is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA. Latest PE of Ind-Swift is 1.45, while 3 year average PE is 1.35. Also latest EV/EBITDA of Ind-Swift is 26.56 while 3yr average is 26.59.
Has the share price of Ind-Swift grown faster than its competition?
Ind-Swift has given better returns compared to its competitors. Ind-Swift has grown at ~38.14% over the last 2yrs while peers have grown at a median rate of 10.31%
Is the promoter bullish about Ind-Swift?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Ind-Swift is 55.58% and last quarter promoter holding is 55.58%.
Are mutual funds buying/selling Ind-Swift?
There is Insufficient data to gauge this.